Handelsavisen
prelaunch
Companies Healthcare COR.CN
CO
COR.CN Diversified Pharmaceuticals

Cor.Cn

$0,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
8,61 %
Op margin
34,8 %
ROE
16,2 %
Net margin
28,0 %
Debt / equity
0,12
Beta
52w range
Volume
3,2k
Day range
$284,23–$289,78
Prev close
$284,47
Open
$285,85
Next earnings
2026-11-09
Ex-dividend
TR 1Y
About

COR.CN operates in the Business Support Services industry, providing industrial services that generate revenue primarily through service contracts and operational support.

Business. COR.CN operates in the Business Support Services industry, providing industrial services that generate revenue primarily through service contracts and operational support.

Classification99 %
SectorHealth Care
Industry groupDiversified Pharmaceuticals
Generated · model-assisted
Sell-side consensus
BUY16 analysts
12 buy4 hold0 sell
Avg 12m price target353,59

Analyst recommendations

16 analysts · consensus Buy
Buy12
Hold4
Sell0
12-month price target
353,59
Consensus of sell-side coverage.
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
16 analysts · indicative
Ownership
T. Rowe Price Investment Management, Inc.
largest disclosed fund holder
Profitability
16,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning COR.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to COR.CN. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressJared Moskowitz — Cencora, Inc. Common Stock2026-05-06 · Democrat · FL · Sale · $1,001 - $15,000
    • CongressJared Moskowitz — Cencora, Inc. Common Stock2026-03-23 · Democrat · FL · Purchase · $1,001 - $15,000
    • CongressGreg Landsman — Cencora, Inc. Common Stock2025-03-27 · Democrat · OH · Sale · $15,001 - $50,000
    • CongressGreg Landsman — Cencora, Inc. Common Stock2024-05-29 · Democrat · OH · Purchase · $15,001 - $50,000

    Pre-earnings brief

    Briefing · model-assisted

    Cencora Inc (COR.O) experienced a major shift in its shareholder base, marked by a significant modification in holdings for investor ID 587. Data detected in late June 2026 indicates a substantial change in the number of shares held by this entity as of March 31, 2026. The records show a fluctuation between holding approximately 4,039 shares, valued at roughly $1.27 million, and 198,969 shares, valued at approximately $62.5 million. This volatility in a single holder's position represents a material change in the company's ownership structure. This movement in holdings is particularly notable given Cencora's broader investor profile. The company currently maintains a top holder count of 38, suggesting a diversified but concentrated ownership base where changes in major positions can signal shifts in institutional sentiment. The specific investor involved in this change adjusted their weight in the company from a negligible 0.0007% to a more substantial 3.61%, or vice versa, depending on the direction of the final reported position. Such a swing underscores the dynamic nature of capital allocation within Cencora's shareholder registry. In addition to these ownership changes, Cencora's risk assessment profile has been updated with new classifications. The company's dilution risk is now categorized as "low," while its liquidity risk has been assessed as "medium." These new fields provide a clearer framework for evaluating the financial stability and capital structure pressures facing the firm. The low dilution risk suggests that existing shareholders are currently protected from significant equity erosion, while the medium liquidity risk indicates a need for continued monitoring of cash flow and short-term obligations. Furthermore, Cencora's taxonomy classification for both activity and economic sector has been updated to "Unclassified." This change, classified with medium severity, may reflect a need for more precise categorization within financial databases or a transition in how the company's operations are defined. Alongside a revised AI analysis narrative, these updates contribute to a more nuanced understanding of Cencora's operational and financial landscape, providing investors with fresh data points to consider alongside the recent holder activity.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    COR.CN operates in the Business Support Services industry, providing industrial services that generate revenue primarily through service contracts and operational support.

    Classification99 %
    SectorHealth Care
    Industry groupDiversified Pharmaceuticals
    AI synthesis
    GENERATED

    COR.CN maintains a strong liquidity position with a current ratio of 0.82, indicating that its current liabilities exceed its current assets. The company's liquidity is assessed as medium, and its free cash flow of $65.42 billion supports its operational flexibility. The debt-to-equity ratio of 0.12 suggests a conservative capital structure, with long-term debt amounting to $76.73 billion and total equity of $617.67 billion.

    In terms of profitability, COR.CN demonstrates a return on equity of 16.25% and a return on assets of 11.38%, which are strong indicators of efficient use of equity and assets. These figures are in line with the industry's preferred metrics, highlighting the company's ability to generate returns relative to its equity and asset base.

    The company's revenue is concentrated in a few key segments, with the majority of its $359.01 billion in revenue derived from its core industrial services. Geographically, the company's exposure is primarily within its domestic market, with limited diversification into international markets.

    COR.CN's growth trajectory is positive, with a strong operating income of $124.99 billion and a net income of $100.36 billion. The company's capital expenditure of $29.22 billion indicates a commitment to maintaining and expanding its operational capabilities.

    The risk assessment for COR.CN indicates a low potential for dilution, with a dilution risk score of low. The company's liquidity risk is moderate, and its credit risk is low, supported by its strong financial position and conservative debt levels.

    Recent events, including filings and transcripts, have not indicated any significant changes in the company's strategic direction or financial health. The company continues to focus on its core industrial services and has not announced any major restructuring or expansion plans.

    Cencora Inc (COR.O) experienced a major shift in its shareholder base, marked by a significant modification in holdings for investor ID 587. Data detected in late June 2026 indicates a substantial change in the number of shares held by this entity as of March 31, 2026. The records show a fluctuation between holding approximately 4,039 shares, valued at roughly $1.27 million, and 198,969 shares, valued at approximately $62.5 million. This volatility in a single holder's position represents a material change in the company's ownership structure. This movement in holdings is particularly notable given Cencora's broader investor profile. The company currently maintains a top holder count of 38, suggesting a diversified but concentrated ownership base where changes in major positions can signal shifts in institutional sentiment. The specific investor involved in this change adjusted their weight in the company from a negligible 0.0007% to a more substantial 3.61%, or vice versa, depending on the direction of the final reported position. Such a swing underscores the dynamic nature of capital allocation within Cencora's shareholder registry. In addition to these ownership changes, Cencora's risk assessment profile has been updated with new classifications. The company's dilution risk is now categorized as "low," while its liquidity risk has been assessed as "medium." These new fields provide a clearer framework for evaluating the financial stability and capital structure pressures facing the firm. The low dilution risk suggests that existing shareholders are currently protected from significant equity erosion, while the medium liquidity risk indicates a need for continued monitoring of cash flow and short-term obligations. Furthermore, Cencora's taxonomy classification for both activity and economic sector has been updated to "Unclassified." This change, classified with medium severity, may reflect a need for more precise categorization within financial databases or a transition in how the company's operations are defined. Alongside a revised AI analysis narrative, these updates contribute to a more nuanced understanding of Cencora's operational and financial landscape, providing investors with fresh data points to consider alongside the recent holder activity.

    Key takeaways
    • COR.CN has a strong return on equity and return on assets, indicating efficient use of capital.
    • The company's liquidity is moderate, with a current ratio of 0.82.
    • COR.CN maintains a conservative capital structure with a low debt-to-equity ratio.
    • The company's growth is supported by a strong operating income and net income.
    • The risk of dilution is low, and the company's credit risk is minimal.
    • "margin_outlook_rationale": "The company's strong return on equity and return on assets suggest that its margins are likely to remain stable or improve in the near term.",

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Revenue grew 9.3% year-over-year to $321.3 billion in fiscal 2025, demonstrating strong top-line expansion momentum.

    Operating income surged 20.8% to $2.63 billion, significantly outpacing revenue growth and indicating improved operational efficiency.

    Analysts project 14.1% upside to a mean price target of $353.59, reflecting broad institutional confidence in future performance.

    Cash conversion ratio of 2.49 exceeds the cohort median of 1.2, suggesting robust ability to turn earnings into cash.

    BEAR CASE · 4

    Net income declined 3.0% year-over-year to $1.55 billion, signaling margin compression despite significant revenue growth.

    Debt-to-equity ratio of 5.08 places the company in the bottom quartile, indicating significantly higher leverage than peers.

    Net margin of 0.48% falls in the bottom quartile of the cohort, revealing thin profitability relative to industry standards.

    Current ratio of 0.90 suggests potential short-term liquidity constraints, as current assets do not fully cover current liabilities.

    In focus — financials by report

    Valuation

    Market price
    $0,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $617.67B
    Net cash
    -$19.91B
    Current ratio
    0.8
    Debt / equity
    0.1
    ROA
    11.4%
    ROE
    16.2%
    Cash conversion
    93.0%
    CapEx / revenue
    -8.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryDiversified Pharmaceuticals1 042,4B node revenueMCK 38,7%COR 30,8%CAH 21,4%DB 3,4%REGN 1,4%BIIB 0,9%ZTS 0,9%GRFS 0,8%Other 1,7%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)COR 30,8% · rank #2 of 40

    Business relationships

    Business relationships22 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries22
    EX21:1cd52da3806aEX21:1cd52da3806aSubsidiarie97%
    EX21:223d659d575bEX21:223d659d575bSubsidiarie97%
    EX21:327f293b7dabEX21:327f293b7dabSubsidiarie97%
    EX21:3cc24092e22aEX21:3cc24092e22aSubsidiarie97%
    EX21:58241672588dEX21:58241672588dSubsidiarie97%
    EX21:6cddc329e863EX21:6cddc329e863Subsidiarie97%
    EX21:7041eeafd871EX21:7041eeafd871Subsidiarie97%
    EX21:78120bb30b09EX21:78120bb30b09Subsidiarie97%
    EX21:7b76b912496fEX21:7b76b912496fSubsidiarie97%
    EX21:8168ff02786cEX21:8168ff02786cSubsidiarie97%
    EX21:9488b18073aeEX21:9488b18073aeSubsidiarie97%
    EX21:b332cbf597c4EX21:b332cbf597c4Subsidiarie97%
    EX21:c118fcd3ef37EX21:c118fcd3ef37Subsidiarie97%
    EX21:cc11d7a16569EX21:cc11d7a16569Subsidiarie97%
    EX21:d30e4f264aceEX21:d30e4f264aceSubsidiarie97%
    EX21:db8405f99635EX21:db8405f99635Subsidiarie97%
    EX21:dcd132625e4eEX21:dcd132625e4eSubsidiarie97%
    EX21:e5b1e7808535EX21:e5b1e7808535Subsidiarie97%
    EX21:eaeca89c62c1EX21:eaeca89c62c1Subsidiarie97%
    EX21:f754fdf2f311EX21:f754fdf2f311Subsidiarie97%
    EX21:f87b79418aa0EX21:f87b79418aa0Subsidiarie97%
    EX21:f97e9957c95eEX21:f97e9957c95eSubsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    Peer comparison7 peers · vs COR · multiples and returns
    MC
    MCK
    Mckesson Corp
    $827,14
    102,6B USD
    P/E
    21,2x
    -15,2 vs self
    Div yield
    0,4 %
    -0,4 vs self
    ROE
    -219,2 %
    -265,0 vs self
    CA
    CAH
    Cardinal Health Inc
    $235,60
    57,0B USD
    P/E
    36,7x
    +0,3 vs self
    Div yield
    0,9 %
    +0,1 vs self
    ROE
    -55,9 %
    -101,7 vs self
    DB
    DB
    DB.V
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    RE
    REGN
    REGENERON PHARMACEUTICALS, INC.
    $757,99
    81,0B USD
    P/E
    15,5x
    -20,9 vs self
    Div yield
    vs self
    ROE
    14,2 %
    -31,5 vs self
    BI
    BIIB
    BIOGEN INC.
    $201,74
    29,6B USD
    P/E
    21,3x
    -15,1 vs self
    Div yield
    vs self
    ROE
    7,5 %
    -38,2 vs self
    ZT
    ZTS
    Zoetis Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    GR
    GRFS
    Grifols SA
    $7,86
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    17,79
    Predicted surprise
    -0,05
    Beat probability
    45 %
    Analysts
    16
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    revision ratio 0,00 · as of 2026-06-25 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-18 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$285,00
    Mean$353,59
    Median$351,56
    High$412,00
    Spot$0,50
    +70618.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin34,8 %Above P75
    Net Margin28,0 %Above P75
    ROE16,2 %Above median
    Capex / Rev-8,1 %Below median
    D/E0,12Below median
    Cash Conv0,93Above median

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-18 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 15 946 sh5 exercises · 2 grants6 insiders
    • Boratto Eva CChief Financial Officer · Restricted Stock Units → Common StockAcquired 21 304grant · 2026-06-29
    • Krikorian LazarusSVP & Chief Accounting Officer · Restricted Stock Units → Common StockAcquired 3 936grant · 2026-04-01
    • Campbell Elizabeth SExecutive Vice President · Restricted Stock Units → Common StockDisposed 12 623exercise · 2026-03-11
    • Cleary James FChief Financial Officer · Restricted Stock Units → Common StockDisposed 12 623exercise · 2026-03-11
    • Battaglia SilvanaExecutive Vice President · Restricted Stock Units → Common StockDisposed 8 415exercise · 2026-03-11
    • Mauch Robert P.Director, President & CEO · Non-qualified Stock Option (Right to Buy) → Common StockDisposed 3 762 @ $86,09exercise · 2026-02-20
    • Mauch Robert P.Director, President & CEO · Non-qualified Stock Option (Right to Buy) → Common StockDisposed 3 763 @ $86,09exercise · 2026-01-20

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • COR.CN Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-311,36 %$2M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,27 %$1 429M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,27 %$2M
    • Invesco QQQ TrustFunds · as of 2026-03-310,19 %$1 253M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,18 %$327M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,15 %$205M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,13 %$252M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,12 %$7 977M
    • FMR LLCInstitutional Investor · as of 2026-03-310,11 %$2 100M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,11 %$1 749M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,10 %$487M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,10 %$2 887M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,10 %$616M
    • Jennison Associates LLCInvestment Managers · as of 2026-03-310,09 %$134M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,09 %$695M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,09 %$4 014M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,09 %$686M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,09 %$293M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,09 %$273M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,09 %$1 424M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,08 %$419M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,06 %$122M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,06 %$132M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,06 %$323M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,06 %$387M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,06 %$87M
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-310,05 %$142M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,05 %$184M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,04 %$154M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,04 %$81M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,04 %$243M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,04 %$176M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,04 %$63M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,02 %$93M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,02 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,01 %$18M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • Fisher InvestmentsInvestment Managers · as of 2026-03-310,00 %$1M

    Leadership

    • John G. ChouExecutive Vice President

    Insider activity

    Net selling3 buys · 3 sellsnet -$1,3M14 insiders · last 365d
    • Battaglia SilvanaExecutive Vice President · Common StockOther 58 @ $240,53$14K · 2026-06-30
    • Campbell Elizabeth SExecutive Vice President · Common StockOther 50 @ $240,53$12K · 2026-06-30
    • Tyler Lauren MDirector · Common StockBought 550 @ $270,23$149K · 2026-06-22
    • DURCAN DERMOT MARKDirector · Common StockBought 4 000 @ $274,19$1,1M · 2026-06-18
    • DURCAN DERMOT MARKDirector · Common StockBought 4 000 @ $266,26$1,1M · 2026-05-28
    • Tyler Lauren MDirector · Common StockOther 99 @ $304,00$30K · 2026-05-01
    • NALLY DENNIS MDirector · Common StockOther 116 @ $304,00$35K · 2026-05-01
    • Cooper EllenDirector · Common StockOther 99 @ $304,00$30K · 2026-05-01
    • Cleary James FChief Financial Officer · Common StockOther 12 623 · 2026-03-11
    • Campbell Elizabeth SExecutive Vice President · Common StockOther 5 842 @ $350,30$2,0M · 2026-03-11
    • Campbell Elizabeth SExecutive Vice President · Common StockOther 12 623 · 2026-03-11
    • Battaglia SilvanaExecutive Vice President · Common StockOther 3 673 @ $350,30$1,3M · 2026-03-11
    • Battaglia SilvanaExecutive Vice President · Common StockOther 8 415 · 2026-03-11
    • Cleary James FChief Financial Officer · Common StockOther 5 409 @ $350,30$1,9M · 2026-03-11
    • Baumann WernerDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • Cooper EllenDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • NALLY DENNIS MDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • Tyler Lauren MDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • Clyburn FrankDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • DURCAN DERMOT MARKDirector · Common StockOther 905 @ $359,28$325K · 2026-03-05
    • GREENBERG LON RDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • Kim Lorence H.Director · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • Miller RedondaDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • Ryerkerk LoriDirector · Common StockOther 557 @ $359,28$200K · 2026-03-05
    • Mauch Robert P.Director, President & CEO · Common StockOther 3 762 @ $86,09$324K · 2026-02-20

    Short positioning

    5.9Mshares short+6.8% vs prior
    3.91days to cover
    39.0%short of daily vol
    7.0Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)
    Index membership
    S&P 500United States

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    COR.CNCanonical
    — · USD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,05M&A prob3 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    COREX21:1cdEX21:223EX21:327EX21:3ccEX21:582EX21:6cdEX21:704EX21:781EX21:7b7EX21:816Diversified Ph
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 13.5%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -45.6%Derived (calculated)
    • Current ratio (FY 2025-12-31): 0.92xDerived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 742.2%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -2.8%Derived (calculated)
    • Shares outstanding (annual): 194.52MSEC XBRL filing
    • Current assets (annual): USD 54.15BSEC XBRL filing
    • Current liabilities (annual): USD 59.13BSEC XBRL filing
    • Cash & equivalents (annual): USD 1.75BSEC XBRL filing
    • Shareholders' equity (annual): USD 1.91BSEC XBRL filing
    • Total assets (annual): USD 78.36BSEC XBRL filing
    • Long-term debt (annual): USD 7.92BSEC XBRL filing
    • Net income (YoY) (2025-09-30 vs 2024-09-30): 3.0%Derived (calculated)
    • Net margin (FY 2025-09-30): 0.5%Derived (calculated)
    • Gross margin (FY 2025-09-30): 3.6%Derived (calculated)
    • Capex (YoY) (2025-09-30 vs 2024-09-30): 37.1%Derived (calculated)
    • Cost of revenue (YoY) (2025-09-30 vs 2024-09-30): 9.1%Derived (calculated)
    • Revenue (YoY) (2025-09-30 vs 2024-09-30): 9.3%Derived (calculated)
    • EPS (basic) (YoY) (2025-09-30 vs 2024-09-30): 5.5%Derived (calculated)
    • EPS (diluted) (YoY) (2025-09-30 vs 2024-09-30): 5.7%Derived (calculated)
    • Operating income (YoY) (2025-09-30 vs 2024-09-30): 20.8%Derived (calculated)
    • Gross profit (YoY) (2025-09-30 vs 2024-09-30): 15.8%Derived (calculated)
    • Operating cash flow (YoY) (2025-09-30 vs 2024-09-30): 11.2%Derived (calculated)
    • Capex (annual): USD 667.98MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-11-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: political_trade_signal (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-30INSIDERCampbell Elizabeth S transacted 50 sh — Executive Vice President ~$12k
    2026-06-30INSIDERBattaglia Silvana transacted 58 sh — Executive Vice President ~$14k
    2026-06-29INSIDERBoratto Eva C acquired 21.3k sh Restricted Stock Units — Chief Financial Officer
    2026-06-23 03:11 UTCHOLDERInstitutional holding changed
    2026-06-23 03:11 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-22 00:00 UTCINSIDER2 insider transactions — 2026-06 · net buy $1.2M
    2026-06-22 00:00 UTCINSIDER2 insider transactions — 2026-06 · net buy $1.2M
    2026-06-22INSIDERTyler Lauren M bought 550 sh — Director ~$149k
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-18INSIDERDURCAN DERMOT MARK bought 4.0k sh — Director ~$1.10M
    2026-06-15FILINGFORM 8-K →
    2026-05-31CONGRESSJared Moskowitz (house) sale shares → $1,001 - $15,000
    2026-05-29FILINGFORM 8-K →
    2026-05-28 00:00 UTCINSIDER4 insider transactions — 2026-05 · net buy $1.2M
    2026-05-28 00:00 UTCINSIDER4 insider transactions — 2026-05 · net buy $1.2M
    2026-05-28INSIDERDURCAN DERMOT MARK bought 4.0k sh — Director ~$1.07M
    2026-05-06FILING10-Q filing →
    2026-05-06FILING8-K filing →
    2026-05-01 04:40 UTCFILINGRegulatory filing →
    2026-05-01INSIDERTyler Lauren M transacted 99 sh — Director ~$30k
    2026-05-01INSIDERNALLY DENNIS M transacted 116 sh — Director ~$35k
    2026-05-01INSIDERCooper Ellen transacted 99 sh — Director ~$30k
    2026-04-01 00:00 UTCINSIDER1 insider transaction — 2026-04 1 derivative
    2026-04-01 00:00 UTCINSIDER1 insider transaction — 2026-04 1 derivative
    2026-04-01INSIDERKrikorian Lazarus acquired 3.9k sh Restricted Stock Units — SVP & Chief Accounting Officer
    2026-03-31CONGRESSJared Moskowitz (house) purchase shares → $1,001 - $15,000
    2026-03-23FILINGFORM 8-K →
    2026-03-17FILINGFORM 8-K →
    2026-03-11 00:00 UTCINSIDER19 insider transactions — 2026-03 · net sell $3.1M 3 derivative
    2026-03-11 00:00 UTCINSIDER19 insider transactions — 2026-03 · net sell $3.1M 3 derivative
    2026-03-11INSIDERCleary James F transacted 12.6k sh — Chief Financial Officer
    2026-03-11INSIDERCampbell Elizabeth S transacted 5.8k sh — Executive Vice President ~$2.05M
    2026-03-11INSIDERCampbell Elizabeth S transacted 12.6k sh — Executive Vice President
    2026-03-11INSIDERBattaglia Silvana transacted 3.7k sh — Executive Vice President ~$1.29M
    2026-03-11INSIDERBattaglia Silvana transacted 8.4k sh — Executive Vice President
    Showing the 40 most recent of 65 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage